Search Results for: darvocet

Featured Stories
Study Suggests Hormonal Contraceptives Linked to Brain Tumor

Study Suggests Hormonal Contraceptives Linked to Increased Brain Tumor Risk

A study of Danish women of reproductive age suggests that long-term use of hormonal contraceptives is associated with an increased risk of brain tumors.

Read More

Decision on Pradaxa Bleeding Lawsuit Multidistrict Litigation Expected Soon

Victims of alleged Pradaxa injuries are awaiting word on whether their lawsuits will be consolidated in a multidistrict litigation. According to a report from The Madison Record, so far just over two dozen Pradaxa bleeding lawsuits have been filed in federal courts throughout the U.S.

Read More

New York City Council Calls for Zadroga Act to be Renewed

New York City Council Calls for Zadroga Act to be Renewed

New York City Council members are calling for the Zadroga Act, which provides compensation and medical treatment to 9/11 victims, to be renewed. According to press release issued Jan. 7, a resolution was introduced by Council Member Margaret Chin, Council Speaker Melissa Mark-Viverito and Council Members Paul Vallone and I. ...

Read More

System for Tracking Prescription Drug Side Effects Flawed

Study Finds System for Tracking Prescription Drug Side Effects Flawed

System for keeping track of dangerous side effects of prescription drugs is flawed because drug makers are submitting incomplete information about problems to the FDA.

Read More

Tentative Ohio Fracking Regulations Criticized as too Lax

Lawmakers in Ohio have tentatively passed new regulations governing hydraulic fracturing (fracking) drilling but they’ve immediately been criticized for being too favorable to the natural gas and oil industries.

Read More

Medtronic Sprint Fidelis Leads Vulnerable to Fracture after ICD Switch

Medtronic Sprint Fidelis leads are vulnerable to fracture following ICD switch, says a new study published in the June issue of the journal Heart Rhythm.

Read More

Canadian Warning Issued for Actos Bladder Cancer Side Effect Risk

Health Canada has become the most recent national drug regulator to issue a warning about Actos and bladder cancer. Last month, the agency warned that interim results from a 10-year-study indicated that patients taking Actos for more than a year faced an increased risk of bladder cancer. Health Canada also ...

Read More

Fracking Should be Kept 600m From Aquifers, Study Says

New research on the safety of hydraulic fracturing (fracking) suggests new wells should not be dug within 600 meters of a water aquifer because underground fractures can extend about that far from a dug well. According to a report from UK’s The Guardian newspaper, researchers and geologists at Durham University have ...

Read More

Canadian Study Confirms Actos Bladder Cancer Risk

A new study conducted by Canadian researchers has found that users of the type 2 diabetes drug, Actos (pioglitazone), may face a higher risk of developing bladder cancer than first thought. The study, published in the British Medical Journal, found that taking Actos for two years doubles the likelihood ...

Read More

Thousands of Darvon, Darvocet Lawsuits Expected

Personal injury attorneys are preparing Darvocet and < "http://www.yourlawyer.com/topics/overview/darvon">Darvon litigation against the makers of propoxyphene-based painkillers. It seems that the alleged cardiac response to the drugs could be fatal with erratic origins that provide no symptoms, noted the Daily Mail. Attorneys … Continue reading

Posted in Pharmaceuticals, Product Recalls, Recalled Drugs |

Motion Filed to Consolidate Darvon, Darvocet Lawsuits in Multidistrict Litigation

Attorneys representing a 31-year-old Queens, New York Woman in a < "http://www.yourlawyer.com/topics/overview/darvocet">Darvocet lawsuit have petitioned the Judicial Panel on Multidistrict Litigation to consolidate all federal lawsuits involving Darvon, Darvocet and other propoxyphene medications in a multidistrict litigation in US District … Continue reading

Posted in Legal News, Pharmaceuticals |

Darvon, Darvocet Recall Delay May Have Killed Thousands

How many Darvon and Darvocet deaths may have occurred while the US Food & Drug Administration (FDA) waited to pull these and other dangerous propoxyphene-based drugs from the market? It’s probably impossible to know for sure, but according to the … Continue reading

Posted in Pharmaceuticals |

Darvon, Darvocet, Other Narcotic Painkillers May Put Elderly at Risk for Heart Attacks, Other Side Effects

Narcotic painkillers, a class of drugs that includes Oxycontin, as well as the now-recalled medications Darvon and Darvocet, may increase the risk of heart attacks and bone fractures in elderly arthritis patients, a new study has found. According to a … Continue reading

Posted in Pharmaceuticals |

Darvocet Lawsuit Filed on Behalf of New York Woman

A < "http://www.yourlawyer.com/topics/overview/darvocet">Darvocet lawsuit has been filed on behalf a 31-year-old New York woman who says the recalled painkiller caused her to suffer a near-fatal cardiac arrhythmia. The plaintiff is being represented by the national < "http://www.yourlawyer.com/">personal injury law firm … Continue reading

Posted in Legal News, Pharmaceuticals |

Darvocet Class Action Lawsuit Says Painkiller Caused Heart Attack

A propoxyphene-containing painkiller has been named in a Darvocet class action lawsuit filed by a woman who claims it caused her to suffer a heart attack. Darvocet, as well as Darvon, were pulled from the market by Xanodyne Pharmaceuticals Inc. … Continue reading

Posted in Pharmaceuticals |

Darvon, Darvocet Recall Came 30 Years Too Late

The Darvon and Darvocet recall announced last month due to the drugs’ association with serious and sometimes fatal heart rhythm problems was about 30 years too late. For at least that long, patient advocates had raised questions about the safety … Continue reading

Posted in Pharmaceuticals |

Darvon, Darvocet Withdrawal Prompts Other Propoxyphene Recalls

Following the earlier Darvon and Darvocet recall by Xanodyne Pharmaceuticals Inc., makers of generic propoxyphene medications have begun recalling their products. Recently, Cornerstone Therapeutics Inc. said it would remove three such propoxyphene products from the market, including Balacet 325. Propoxyphene … Continue reading

Posted in Pharmaceuticals |

Darvon, Darvocet Patients Should Discuss Alternatives with Their Doctors

The recent Darvocet and Darvon recall from the market because of their association with dangerous, and even fatal heart rhythm problems has caused consternation among people who relied on Darvon and Darvocet to manage chronic pain. But according to a recent article … Continue reading

Posted in Pharmaceuticals |

Darvon, Darvocet Withdrawal Late in Coming

The decision to finally pull Darvon and Darvocet from the market has spawned criticism of the US Food & Drug Administration (FDA) by those who say it waited too long to act on the dangerous painkillers. Darvon and Darvocet have … Continue reading

Posted in Pharmaceuticals |

© 2005-2019 Parker Waichman LLP ®. All Rights Reserved.